HomeBLISSGVS • NSE
add
Bliss GVS Pharma Ltd
Previous close
₹123.21
Day range
₹122.61 - ₹126.50
Year range
₹92.15 - ₹185.50
Market cap
13.14B INR
Avg Volume
356.92K
P/E ratio
22.27
Dividend yield
0.40%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 2.10B | 4.83% |
Operating expense | 739.85M | 20.32% |
Net income | 238.02M | -13.79% |
Net profit margin | 11.31 | -17.81% |
Earnings per share | — | — |
EBITDA | 281.54M | -31.46% |
Effective tax rate | 29.15% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.20B | 34.93% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 10.48B | — |
Shares outstanding | 104.86M | — |
Price to book | 1.28 | — |
Return on assets | — | — |
Return on capital | 4.87% | — |
Cash Flow
Net change in cash
(INR) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 238.02M | -13.79% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1984
Website
Employees
831